Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.09USD
21 May 2018
Change (% chg)

$0.12 (+6.09%)
Prev Close
$1.97
Open
$1.86
Day's High
$2.09
Day's Low
$1.86
Volume
1,329
Avg. Vol
8,751
52-wk High
$3.91
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 0.000
Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.006
Jun '16 0.00 -0.010
Mar '16 -0.011
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 223.30 32.53
P/E High - Last 5 Yrs. 65.61 281.11 47.11
P/E Low - Last 5 Yrs. 65.61 95.06 24.61
Beta 0.36 0.75 0.79
Price to Sales (TTM) -- 261.80 8.85
Price to Book (MRQ) 0.28 23.37 4.22
Price to Tangible Book (MRQ) 3.01 26.33 5.79
Price to Cash Flow (TTM) -- 127.56 21.98
% Owned Institutions 3.62 10.86 2.39

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.34 4.12
Payout Ratio(TTM) -- 47.06 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.67 5.06
Sales (TTM) vs TTM 1 Yr. Ago -- 146.75 12.43
Sales - 5 Yr. Growth Rate -- 30.07 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 100.00 -162.81 32.52
EPS (TTM) vs TTM 1 Yr. Ago 91.48 -- --
EPS - 5 Yr. Growth Rate -- 46.61 8.54
Capital Spending - 5 Yr. Growth Rate -- 38.65 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.50
Current Ratio (MRQ) 20.69 6.55 3.56
LT Debt to Equity (MRQ) 0.00 22.13 12.76
Total Debt to Equity (MRQ) 0.00 25.64 15.69
Interest Coverage (TTM) -- -185.60 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.90 54.71
Gross Margin - 5 Yr. Avg. -- 54.92 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -155.94 15.91
Operating Margin (TTM) -- -929.27 -1.83
Operating Margin - 5 Yr. Avg. -- -168.52 11.18
Pre-Tax Margin (TTM) -- -813.68 0.25
Pre-Tax Margin - 5 Yr. Avg. -- -174.04 11.38
Net Profit Margin (TTM) -- -804.80 -3.16
Net Profit Margin - 5 Yr. Avg. -- -173.41 7.67
Effective Tax Rate (TTM) -- 14.53 31.64
Effective Tax Rate - 5 Yr. Avg. -- 18.17 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,415,270 726,901,196
Net Income/Employee (TTM) -- -1,532,715 84,519,443
Receivable Turnover (TTM) -- 16.37 5.67
Inventory Turnover (TTM) -- 2.45 3.53
Asset Turnover (TTM) 0.00 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -16.27 -5.67 9.99
Return on Assets - 5 Yr. Avg. -30.36 -0.55 11.11
Return on Investment (TTM) -17.41 -8.07 12.63
Return on Investment - 5 Yr. Avg. -36.94 2.59 14.39
Return on Equity (TTM) -24.77 -10.87 14.50
Return on Equity - 5 Yr. Avg. -35.99 -2.77 15.75
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 82.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.62%
# of Holders: 6
Total Shares Held: 186,024
3 Mo. Net Change: 6,526
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.